Skip to main content
. 2019 Nov 25;14(5):908–911. doi: 10.1177/1932296819888662

Table 1.

Demographic and Baseline Clinical Characteristics.

Parameter HbA1c evaluation cohort (n = 740)
Age, y 53.8 ± 8.8
Female, # (%) 468 (63)
Body mass index 35.6 ± 8.5a
Baseline HbA1c, % 7.7 ± 1.7
Medication use, # (%)
 Sulfonylurea 192 (25.9)
 Insulin 230 (31.1)
CGM delivered, # (%) 340 (45.9)
Geography, # (%)18
 Urban 512b (70.0)
 Rural 222b (30.0)

Data are mean ± SD unless otherwise indicated.

CGM, continuous glucose monitor.

a

n = 663, bn = 734.